Furthermore, Kaplan–Meier survival analysis and Cox proportional hazards analysis demonstrated that luminal BC patients with high levels of lncRNA NCALD expression exhibited significantly reduced overall and disease-free survival rates. This evidence concerns the gene NCALD and breast cancer.